Liver-directed gene therapy for murine glycogen storage disease type Ib.

about

The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.

P2860

Q55032191-5965136E-2C8A-4B3D-A5A2-883B78737F97

P2860

Liver-directed gene therapy for murine glycogen storage disease type Ib.

Item

http://www.wikidata.org/entity/Q41925391

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Liver-directed gene therapy for murine glycogen storage disease type Ib.

@en

type

Item

label

Liver-directed gene therapy for murine glycogen storage disease type Ib.

@en

prefLabel

Liver-directed gene therapy for murine glycogen storage disease type Ib.

@en

P1476

Liver-directed gene therapy for murine glycogen storage disease type Ib

@en

P2093

Goo-Young Kim

http://www.w3.org/2001/XMLSchema#string

Janice Y Chou

http://www.w3.org/2001/XMLSchema#string

Javier Anduaga

http://www.w3.org/2001/XMLSchema#string

Joon Hyun Kwon

http://www.w3.org/2001/XMLSchema#string

Matthew F Starost

http://www.w3.org/2001/XMLSchema#string

Young Mok Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex

Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse

Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy

Correction of glycogen storage disease type 1a in a mouse model by gene therapy

Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes

Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter

Metabolic engineering with recombinant adenoviruses.

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.

P304

4395-4405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDX325

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian C Mansfield

Jun-Ho Cho

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28973635

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5886224

http://www.w3.org/2001/XMLSchema#string

Liver-directed gene therapy for murine glycogen storage disease type Ib.

about

P2860

P2860

Liver-directed gene therapy for murine glycogen storage disease type Ib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932